XORTX Therapeutics has entered a $2,500,000 investor-relations agreement with IR Agency for Marketing and news distribution beginning September 3, 2026. The fee is fully earned when paid and cannot be refunded, while the consultant offers no guarantee that the program will increase XRTX trading Volume or price.

Key Highlights

  • XORTX Therapeutics’ TSXV delisting received final approval on August 28, 2026, and took effect at the close of Business September 1, 2026.
  • The prior IR arrangement ended August 7, 2026, with $2,500,000 returned to XORTX Therapeutics on August 14, 2026.
  • IR Agency will not solicit securities orders, provide Investment advice or guarantee higher trading volume or price.

XORTX Therapeutics Inc. (NASDAQ: XRTX) has re-engaged IR Agency under a $2,500,000 investor-relations agreement covering marketing and news distribution. The program begins September 3, 2026, after the company completed its voluntary departure from the TSXV, while its common shares remain listed on the Nasdaq Capital Market.

$2.5M Marketing Agreement Terms

The revised arrangement followed the termination and rescission of an earlier agreement on August 7, 2026. Final TSXV approval arrived on August 28, 2026, and the delisting became effective at the close of business September 1, 2026. The new agreement provides marketing and Advertising services, including company profiles and distribution of company news, with the fee payable in advance by wire transfer. Either party can terminate the arrangement by written notice. The agreement can be extended by mutual consent, and XORTX Therapeutics reserved the returned funds for future investor-relations spending.

IR Agency's Responsibility for Market Response

IR Agency does not guarantee that the marketing program will increase XRTX trading volume or raise its trading price. The consultant also assumes no responsibility for the amount or duration of any potential increase. The agreement states that IR Agency assumes no responsibility for market response, trading volume, or price changes.